Metaproterenol, isoproterenol, and their bisdimethylcarbamate derivatives as human cholinesterase inhibitors

Journal of Medicinal Chemistry

Volumn 55, Issue 15, 2012, Pages 6716-6723

  Bosak, Anita ^a   Smilović, Ivana Gazić ^b   Šinko, Goran ^a   Vinković, Vladimir ^b   Kovarik, Zrinka ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; BAMBUTEROL; BISDIMETHYLCARBAMATE DERIVATIVE; CARBAMIC ACID DERIVATIVE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; ISOPRENALINE; ORCIPRENALINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION;

ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; CARBAMATES; CHOLINESTERASE INHIBITORS; ENZYME ASSAYS; HUMANS; ISOPROTERENOL; METAPROTERENOL; MODELS, MOLECULAR; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84864916499     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm300289k     Document Type: Article

References (28)

1. Waldeck, B. β-Adrenoceptor agonists and asthma-100 years of development Eur. J. Pharmacol. 2002, 445, 1-12
2. Testa, B. Prodrug research: futile or fertile? Biochem. Pharmacol. 2004, 68, 2097-2106
3. Lockridge, O.; Masson, P. Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk Neurotoxicology 2000, 21, 113-126
4. Reiner, E.; Radić, Z. Mechanism of action of cholinesterase inhibitor. In Cholinesterases and Cholinesterase Inhibitors, 1 st ed.; Giacobini, E., Ed.; Martin Dunitz Ltd.: London, 2000; pp 103-121.
5. Tunek, A.; Svensson, L.-Å. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood Drug Metab. Dispos. 1988, 16, 759-764
6. Kovarik, Z.; Radić, Z.; Grgas, B.; Škrinjarić- Špoljarić, M.; Reiner, E.; Simeon-Rudolf, V. Amino acids residues involved in the interaction of acetylcholinesterase with carbamates Ro 02-0683 and bambuterol, and with terbutaline Biochim. Biophys. Acta 1999, 1433, 261-271
7. Bosak, A.; Gazić, I.; Vinković, V.; Kovarik, Z. Amino acids involved in stereoselective inhibition of cholinesterases with bambuterol Arch. Biochem. Biophys. 2008, 471, 72-76
8. Gazić, I.; Bosak, A.; Šinko, G.; Vinković, V.; Kovarik, Z. Preparative HPLC separation and stereoselective inhibition of human cholinesterases Anal. Bioanal. Chem. 2006, 385, 1513-1519
9. Bosak, A.; Gazić, I.; Vinković, V.; Kovarik, Z. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers Chem.-Biol. Interact. 2008, 175, 192-195
10. Liederer, B. M.; Borchardt, R. T. Enzymes involved in the bioconversion of ester-based prodrugs J. Pharm. Sci. 2006, 95, 1177-1195
11. Souza, R. L. R.; Mikami, L. R.; Maegawa, R. O. B.; Chautard-Freire-Maia, E. A. Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample Mol. Genet. Metab. 2005, 84, 349-353
12. Jensen, F. S.; Viby-Mogensen, J. Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years' experience with the Danish Cholinesterase Research Unit. Acta Anaesthesiol. Scand. 1995, 39, 150-156
13. Hartley, D.; Middlemis, D. Absolute configuration of the optical isomers of salbutamol J. Med. Chem. 1971, 14, 895-896
14. Källström, B.-L.; Sjöberg, J.; Waldeck, B. Steric aspects of formoterol and terbutalin: Is there an adverse effect of the distomer on airway smooth muscle function? Chirality 1996, 8, 567-573
15. Kovarik, Z.; Radić, Z.; Berman, H. A.; Simeon-Rudolf, V.; Reiner, E.; Taylor, P. Acetylcholinesterase active centre and gorge conformation analysed by combinatorial mutations and enantiomeric phosphonates Biochem. J. 2003, 373, 33-40
16. Bosak, A.; Primožič, I.; Oršulić, M.; Tomić, S.; Simeon-Rudolf, V. Enantiomers of quinuclidin-3-ol derivatives: Resolution and interactions with human cholinesterases Croat. Chem. Acta 2005, 78, 121-128
17. Kovarik, Z.; Simeon-Rudolf, V. Interaction of human butyrylcholinesterase variants with bambuterol and terbutaline J. Enzyme Inhib. Med. Chem. 2004, 19, 113-117
18. Masson, P.; Adkins, S.; Gouet, P.; Lockridge, O. Recombinant human butyrylcholinesterase G390V, the fluoride-2 variant, expressed in Chinese hamster ovary cells, is a low affinity variant J. Biol. Chem. 1993, 268, 14329-14341
19. Simeon-Rudolf, V.; Juršić, B. Heterogeneity of human serum cholinesterase revealed by thiocholine substrates Period. Biol. 1996, 98, 331-335
20. Tan, W.; Cheng, J. L. R-bambuterol, its preparation and therapeutic uses. U.S. Patent US7495028B2, 2009.
21. Kovarik, Z.; Simeon-Rudolf, V. An improvement in segregation of human butyrylcholinesterase phenotypes having the fluoride-resistant variants Arh. Hig. Rada Toksikol. 2003, 54, 239-244
22. Ellman, G. L.; Courtney, K. D.; Andres, V.; Featherstone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity Biochem. Pharmacol. 1961, 7, 88-95
23. Eyer, P.; Worek, F.; Kiderlen, D.; Sinko, G.; Stuglin, A.; Simeon-Rudolf, V.; Reiner, E. Molar absorption coefficients for the reduced Ellman reagent: reassessment Anal. Biochem. 2003, 312, 224-227
24. Main, R. Affinity and phosphorylation constants for the inhibition of esterases by organophosphates Science 1964, 14, 992-993
25. Aldridge, W. N.; Reiner, E. Enzyme Inhibitors as Substrates. Interaction of Esterases with Esters of Organophosphorus and Carbamic Acids; North-Holland: New York, 1972.
26. Accelrys Software Inc., San Diego, CA, 2005-2009.
27. Ngamelue, M. N.; Homma, K.; Lockridge, O.; Asojoa, O. A. Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun. 2007, F63, 723-727
28. Carletti, E.; Li, H.; Li, B.; Ekström, F.; Nicolet, Y.; Loiodice, M.; Gillon, E.; Froment, M. T.; Lockridge, O.; Schopfer, L. M.; Masson, P.; Nachon, F. Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation J. Am. Chem. Soc. 2008, 130, 16011-16020